Antiseizure medication reduction in long‐term video‐electroencephalographic monitoring for presurgical evaluation: A multicenter safety and efficacy analysis.

Saved in:
Bibliographic Details
Title: Antiseizure medication reduction in long‐term video‐electroencephalographic monitoring for presurgical evaluation: A multicenter safety and efficacy analysis.
Authors: van Griethuysen, Renate (AUTHOR), van Asch, Charlotte J. J. (AUTHOR), Otte, Willem M. (AUTHOR), Lamberink, Herm (AUTHOR), Sander, Josemir W. (AUTHOR), Bourez‐Swart, Mireille D. (AUTHOR), de Jong, Lotte (AUTHOR), Colon, Albert J. (AUTHOR), Braun, Kees P. J. (AUTHOR), Kalina, Adam (AUTHOR), Jahodová, Alena (AUTHOR), Schulze‐Bonhage, Andreas (AUTHOR), Bělohlávková, Anežka (AUTHOR), Tranberg, Anna Edelvik (AUTHOR), Korff, Christian (AUTHOR), Reus, Elise (AUTHOR), Cox, Fieke (AUTHOR), Visser, Gerhard (AUTHOR), van Scheepen, Hannah (AUTHOR), Tadema, Helen (AUTHOR)
Source: Epilepsia (Series 4). Nov2025, Vol. 66 Issue 11, p4490-4500. 11p.
Subjects: Anticonvulsants, Partial epilepsy, Seizures (Medicine), Surgical complications, Electroencephalography, Medical research, Patient safety, Medical consultation
Abstract: Objective: In people with refractory focal epilepsy, long‐term video‐electroencephalographic monitoring (LT‐VEEG) is a valuable tool for surgical evaluation. Antiseizure medication (ASM) is often tapered during LT‐VEEG. ASM reduction may increase the risk of complications such as status epilepticus, and efficacy has not been established. We characterized contributing factors to successful and safe LT‐VEEG within a large multicenter dataset. Methods: Adults and children were included from eight tertiary epilepsy centers in Europe for whom LT‐VEEG was part of the preoperative assessment for epilepsy surgery from May 2017 until January 2022. We collected demographics, baseline seizure frequency, ASM use and reductions or complete discontinuation, outcome (successful LT‐VEEG), and complications during ASM withdrawal/LT‐VEEG. We performed multivariate regression analysis to determine factors contributing to risks of complications and successful LT‐VEEG. Results: We included 843 people. LT‐VEEG was successful in 70%. ASM was tapered in 756 persons (90%). Five hundred forty‐four persons started reduction of ASM before LT‐VEEG, of whom 72% reduced it at home. Baseline seizure frequency had a strong influence on ASM withdrawal policy. In people with a lower baseline seizure frequency, ASM was more likely to be tapered, and the reduction was more often initiated before the start of the LT‐VEEG. The extent of ASM dose reduction was identified as a critical factor contributing to a successful LT‐VEEG. ASM reduction increased the chance of complications; 10% had a complication compared to 1% without reduction. Starting ASM reduction before LT‐VEEG did not increase the risk of complications. Significance: ASM reduction contributes to a successful LT‐VEEG in people with a lower baseline seizure frequency and is relatively safe, taking specific factors into account. The risk of adverse events is higher when ASM is reduced, regardless of timing or setting (outpatient vs. in‐hospital). [ABSTRACT FROM AUTHOR]
Copyright of Epilepsia (Series 4) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 189711248
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antiseizure medication reduction in long‐term video‐electroencephalographic monitoring for presurgical evaluation: A multicenter safety and efficacy analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22van+Griethuysen%2C+Renate%22">van Griethuysen, Renate</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Asch%2C+Charlotte+J%2E+J%2E%22">van Asch, Charlotte J. J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Otte%2C+Willem+M%2E%22">Otte, Willem M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lamberink%2C+Herm%22">Lamberink, Herm</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sander%2C+Josemir+W%2E%22">Sander, Josemir W.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bourez‐Swart%2C+Mireille+D%2E%22">Bourez‐Swart, Mireille D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jong%2C+Lotte%22">de Jong, Lotte</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colon%2C+Albert+J%2E%22">Colon, Albert J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braun%2C+Kees+P%2E+J%2E%22">Braun, Kees P. J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalina%2C+Adam%22">Kalina, Adam</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jahodová%2C+Alena%22">Jahodová, Alena</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schulze‐Bonhage%2C+Andreas%22">Schulze‐Bonhage, Andreas</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bělohlávková%2C+Anežka%22">Bělohlávková, Anežka</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tranberg%2C+Anna+Edelvik%22">Tranberg, Anna Edelvik</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Korff%2C+Christian%22">Korff, Christian</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reus%2C+Elise%22">Reus, Elise</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cox%2C+Fieke%22">Cox, Fieke</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Visser%2C+Gerhard%22">Visser, Gerhard</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Scheepen%2C+Hannah%22">van Scheepen, Hannah</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tadema%2C+Helen%22">Tadema, Helen</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Epilepsia+%28Series+4%29%22">Epilepsia (Series 4)</searchLink>. Nov2025, Vol. 66 Issue 11, p4490-4500. 11p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Anticonvulsants%22">Anticonvulsants</searchLink><br /><searchLink fieldCode="DE" term="%22Partial+epilepsy%22">Partial epilepsy</searchLink><br /><searchLink fieldCode="DE" term="%22Seizures+%28Medicine%29%22">Seizures (Medicine)</searchLink><br /><searchLink fieldCode="DE" term="%22Surgical+complications%22">Surgical complications</searchLink><br /><searchLink fieldCode="DE" term="%22Electroencephalography%22">Electroencephalography</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+research%22">Medical research</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+safety%22">Patient safety</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+consultation%22">Medical consultation</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: In people with refractory focal epilepsy, long‐term video‐electroencephalographic monitoring (LT‐VEEG) is a valuable tool for surgical evaluation. Antiseizure medication (ASM) is often tapered during LT‐VEEG. ASM reduction may increase the risk of complications such as status epilepticus, and efficacy has not been established. We characterized contributing factors to successful and safe LT‐VEEG within a large multicenter dataset. Methods: Adults and children were included from eight tertiary epilepsy centers in Europe for whom LT‐VEEG was part of the preoperative assessment for epilepsy surgery from May 2017 until January 2022. We collected demographics, baseline seizure frequency, ASM use and reductions or complete discontinuation, outcome (successful LT‐VEEG), and complications during ASM withdrawal/LT‐VEEG. We performed multivariate regression analysis to determine factors contributing to risks of complications and successful LT‐VEEG. Results: We included 843 people. LT‐VEEG was successful in 70%. ASM was tapered in 756 persons (90%). Five hundred forty‐four persons started reduction of ASM before LT‐VEEG, of whom 72% reduced it at home. Baseline seizure frequency had a strong influence on ASM withdrawal policy. In people with a lower baseline seizure frequency, ASM was more likely to be tapered, and the reduction was more often initiated before the start of the LT‐VEEG. The extent of ASM dose reduction was identified as a critical factor contributing to a successful LT‐VEEG. ASM reduction increased the chance of complications; 10% had a complication compared to 1% without reduction. Starting ASM reduction before LT‐VEEG did not increase the risk of complications. Significance: ASM reduction contributes to a successful LT‐VEEG in people with a lower baseline seizure frequency and is relatively safe, taking specific factors into account. The risk of adverse events is higher when ASM is reduced, regardless of timing or setting (outpatient vs. in‐hospital). [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Epilepsia (Series 4) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=189711248
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/epi.18572
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 4490
    Subjects:
      – SubjectFull: Anticonvulsants
        Type: general
      – SubjectFull: Partial epilepsy
        Type: general
      – SubjectFull: Seizures (Medicine)
        Type: general
      – SubjectFull: Surgical complications
        Type: general
      – SubjectFull: Electroencephalography
        Type: general
      – SubjectFull: Medical research
        Type: general
      – SubjectFull: Patient safety
        Type: general
      – SubjectFull: Medical consultation
        Type: general
    Titles:
      – TitleFull: Antiseizure medication reduction in long‐term video‐electroencephalographic monitoring for presurgical evaluation: A multicenter safety and efficacy analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Griethuysen, Renate
      – PersonEntity:
          Name:
            NameFull: van Asch, Charlotte J. J.
      – PersonEntity:
          Name:
            NameFull: Otte, Willem M.
      – PersonEntity:
          Name:
            NameFull: Lamberink, Herm
      – PersonEntity:
          Name:
            NameFull: Sander, Josemir W.
      – PersonEntity:
          Name:
            NameFull: Bourez‐Swart, Mireille D.
      – PersonEntity:
          Name:
            NameFull: de Jong, Lotte
      – PersonEntity:
          Name:
            NameFull: Colon, Albert J.
      – PersonEntity:
          Name:
            NameFull: Braun, Kees P. J.
      – PersonEntity:
          Name:
            NameFull: Kalina, Adam
      – PersonEntity:
          Name:
            NameFull: Jahodová, Alena
      – PersonEntity:
          Name:
            NameFull: Schulze‐Bonhage, Andreas
      – PersonEntity:
          Name:
            NameFull: Bělohlávková, Anežka
      – PersonEntity:
          Name:
            NameFull: Tranberg, Anna Edelvik
      – PersonEntity:
          Name:
            NameFull: Korff, Christian
      – PersonEntity:
          Name:
            NameFull: Reus, Elise
      – PersonEntity:
          Name:
            NameFull: Cox, Fieke
      – PersonEntity:
          Name:
            NameFull: Visser, Gerhard
      – PersonEntity:
          Name:
            NameFull: van Scheepen, Hannah
      – PersonEntity:
          Name:
            NameFull: Tadema, Helen
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 00139580
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Epilepsia (Series 4)
              Type: main
ResultId 1